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Abstract  
 
The blood-air barrier in the lung consists of the alveolar epithelium, the underlying 
capillary endothelium, their basement membranes and the interstitial space between 
the cell layers. Little is known about the interactions between the alveolar and the 
blood compartment. The aim of the present study was to gain first insights into the 
possible interplay between these two neighboured cell layers. We established an in 
vitro Transwell model of the alveolar epithelium based on human cell line H441 and 
investigated the influence of conditioned medium obtained from human lung 
endothelial cell line HPMEC-ST1.6R on the barrier properties of the H441 layers. As 
control for tissue specificity H441 layers were exposed to conditioned medium from 
human brain endothelial cell line hCMEC/D3. Addition of dexamethasone was 
necessary to obtain stable H441 cell layers. Moreover, dexamethasone increased 
expression of cell type I markers (caveolin-1, RAGE) and cell type II marker SP-B, 
whereas decreased the transepithelial electrical resistance (TEER) in a concentration 
dependent manner. Soluble factors obtained from the lung endothelial cell line 
increased the barrier significantly proven by TEER values and fluorescein 
permeability on the functional level and by the differential expression of tight 
junctional proteins on the molecular level. In contrast to this, soluble factors derived 
from brain endothelial cells weakened the barrier significantly. In conclusion, soluble 
factors from lung endothelial cells can strengthen the alveolar epithelium barrier in 
vitro, which suggests communication between endothelial and epithelial cells 
regulating the integrity of the blood-air barrier.  
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1. Introduction 
 
The blood-air interface in the lung represents one of the vital barriers in the human 
body. The alveoli of the human lung - with an area of approximately 100–140 m2 - are 
functionally the most important element of the lung (Gehr et al., 1978). The alveolar 
epithelial barrier plays a central role in lung diseases, like acute lung injury (ALI) and 
its most severe extreme form, the acute respiratory distress syndrome (ARDS) 
(Maniatis et al., 2008; Matthay, 1994). A key function of the epithelium is the 
formation of diffusion barriers that allow the generation and maintenance of 
compartments with different compositions, a fundamental requirement for the 
physiological organ function like in the lung (Gorin and Stewart, 1979; Balda and 
Matter, 1998). The lung alveolar epithelium in vivo consists of two epithelial cell 
types, the terminally differentiated squamous alveolar epithelial type I (ATI) cell, 
which constitutes approximately 93% of the alveolar epithelial surface area, and the 
surfactant-producing cuboidal alveolar epithelial type II (ATII) cell (Crapo et al., 
1992). The major functions of ATII cells are surfactant synthesis, transepithelial ions 
and water movement as well as regeneration of alveolar epithelium after lung injury 
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(Uhal, 1997). The main functions of ATI cells are the control of peptide growth 
factors metabolism, transcellular ion transport, alveolar fluid regulation and immune 
modulation (Williams, 2003). It is believed that ATII cells are the sole progenitor for 
ATI cells (Fehrenbach, 2001). In ATI cells the caveolin-1 synthesis and the formation 
of caveolae are discussed as a characteristic feature of an ATI-like cell phenotype in 
the alveolar epithelium in vivo and in vitro (Campbell et al., 1999; Kasper et al., 1998; 
Kunzmann et al., 2011; Matthay, 1994). The caveolae membrane system is of interest 
because of its important transport function of molecules across the blood-air barrier in 
the lung (Gumbleton et al., 2000). As a second ATI marker the receptor for advanced 
glycation end-products (RAGE) was discussed, especially as a marker of ATI cell 
injury in ALI (Uchida et al., 2006). In comparison, surfactant proteins are restricted to 
the ATII phenotype; especially surfactant protein B (SP-B) and C (SP-C) are known 
to be synthesized with a high specificity by ATII cells (Phelps and Floros, 1991a; 
Weaver et al., 1988). In addition, glucocorticoids enhance fetal lung maturation by 
increasing production of SP-B in ATII cells (Phelps and Floros, 1991b; Ladenburger 
et al., 2010). Cell-cell contacts within the alveolar epithelium are sealed by tight 
junctions. Tight junctions, located at the most apical region of lateral membranes of 
epithelial cells, create a paracellular barrier in epithelial and endothelial cell layers, 
which protect the underlying tissue from the external environment (Forster, 2008; 
Rodriguez-Boulan and Nelson, 1989). Two different classes of integral membrane 
proteins constitute the tight junction strands in epithelial cells and endothelial cells, 
occludin and members of the claudin protein family, which are responsible for 
changes in the electrolyte and solute permeability in cells layers (Forster, 2008). The 
flux of fluid, ions, macromolecules, and inflammatory cells across airway epithelium 
depends in part upon the integrity of its apico-lateral tight junctions (Godfrey, 1997).  
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Because of the complexity of the pulmonary alveolar system, little is known about the 
molecular interactions between alveolar epithelial and endothelial cells. Up to now 
only few reports were published supporting the idea of a functional unit at the blood-
air barrier consisting of alveolar epithelial and endothelial cells (Hermanns et al., 
2004, 2009, 2010). Therefore, the establishment of in vitro models of the alveolar 
epithelial barrier, which could mimic different conditions in the alveolar region, 
would be useful to analyze the role of lung endothelial cells. Ideally, the in vitro 
model would form a tight barrier and consist of cells expressing ATI and ATII cell 
markers such as caveolin-1, RAGE and SP-B. NCI H441 cells have emerged as a 
well-established model system for distal pulmonary epithelial cells (Hermanns et al., 
2004; Shlyonsky et al., 2005).  
The aim of this study was to establish an alveolar cell culture model based on human 
cell line H441 and to use this model to study the influence of soluble factors derived 
from lung endothelial cells (HPMEC-ST1.6R) on the alveolar epithelium barrier. 
Human cell line HPMEC-ST1.6R was chosen as a model of the lung endothelium 
since it was reported that only HPMEC-ST1.6R exhibited the major constitutive and 
inducible endothelial cell characteristics and showed an angiogenic response on 
Matrigel similar to that of primary HPMEC in contrast to several other endothelial 
cell lines (Unger et al., 2002). Human brain endothelial cell line hCMEC/D3 
represents an established model of the human blood-brain barrier (Weksler et al., 
2005) and was used to check if possible effects of the lung endothelial cells on the 
alveolar epithelium model are tissue-specific.  
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2. Material and Methods 
 
2.1. Cell culture 
Human lung epithelial cell line H441 was purchased from ATCC. Cells were 
maintained in RPMI1640 (R8758, Sigma, Munich, Germany) supplemented with 10% 
FCS, 100 U/ml penicillin, 100 µg/ml streptomycin, 2 mol/l Glutamax I, 1x ITS (100x 
ITS, 41400-045) (all from Gibco®, Life Technologies GmbH, Darmstadt, Germany) 
and 1 mol/l Na-pyruvate (L0473, Biochrom, Berlin, Germany) and were subcultured 
in a ratio 1:6 on gelatine (0.5%) coated cell culture tissue flasks (GreinerBioone, 
Frickenhausen, Germany) once a week. Human lung endothelial cell line HPMEC-
ST1.6R were a kind gift from Prof. Kirkpatrick and Dr. Unger of the University 
Hospital Mainz in Germany (Krump-Konvalinkova et al., 2001). They were cultured 
on gelatine coated flasks in M199 supplemented with 10% FCS, 100 U/ml penicillin, 
100 µg/ml streptomycin, 2 mol/l Glutamax I (all from Gibco®, Life Technologies 
GmbH), 25 µg/ml sodium heparin (H3149, Sigma) and 25 µg/ml ECGS (E2759, 
Sigma) and were trypsinized in a ratio of 1:8 once a week. Human brain endothelial 
cell line hCMEC/D3 were obtained from Prof. Couraud (Weksler et al., 2005) and 
were maintained in EBM-2 (C-4147, Lonza, Cologne, Germany) medium 
supplemented according to the manufacturer’s instruction with the components of the 
EGM®-2 bullet kit (C-3162, Lonza, FBS, VEGF, R3-IGF-1, hEGF, hbFGF, heparin, 
ascorbic acid, gentamycine and amphotericin B) without hydrocortisone. hCMEC/D3 
cells were splitted in a ratio of 1:3 onto gelatine coated cell culture flasks once a 
week. Growth media were renewed every 2-3 days. In order to obtain soluble factors 
secreted from HPMEC-ST1.6R and hCMEC/D3 cells growth medium supernatants 
were collected from non-confluent cell layers after 3-5 days after seeding on 75 cm2 
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tissue flasks and sterile-filtered before usage. The terms ST1, ST1-cond., D3 and D3-
cond. are used in the text for fresh or conditioned (cond.) growth medium of the 
corresponding cells (ST1=HPMEC-ST1.6R, D3=hCMEC/D3). H441 cells were used 
between passages 56-76, HPMEC-ST1.6R between passages 30-37 and hCMEC/D3 
between passages 17-34.  
 
2.2. Transwell model experiments 
For Transwell insert experiments H441 cells were seeded at a cell density of 23,000 
cells/cm2 onto collagen-I (0.01%, C7661, Sigma) coated 6-well inserts (353090, BD, 
Heidelberg, Germany, pore size 0,4 µm, PVDF, transparent, apical volume 2 ml, 
basolateral volume 3 ml). Medium was renewed every 2-3 days. After five days of 
culture it was started to add dexamethasone (10, 100, 300 or 1000 nmol/l) to the 
apical side with every medium change in a ratio of 1:1000 of the appropriate ethanolic 
stock solution. In order to assess the development of the barrier properties the 
transepithelial electrical resistance (TEER) was determined using a WPI device with 
chopstick electrodes (World Presicion Instruments, Berlin, Germany) as previously 
published (Neuhaus et al., 2008). In addition to the TEER measurement, transport 
studies with the paracellular marker fluorescein were undertaken. 10 µmol/l 
fluorescein was added in the apical compartment to begin the transport studies. 300 µl 
samples were taken after 15, 45, 105, 165 and 225 minutes from the basolateral side 
and were replaced after each sampling step with 300 µl fresh, prewarmed H441 
medium to maintain the same hydrostatic pressure conditions during the entire 
transport experiment. Fluorescence of samples, stock solution and supernatants of the 
apical compartment after the end of the experiment (90 µl/well in a black 96-well 
plate from GreinerBioone) were measured with a Tecan GeniosPro (excitation 
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wavelength: 485 nm; emission wavelength: 535 nm). Calculation of the permeability 
coefficients was accomplished according the clearance principle as previously 
published (Neuhaus et al., 2008) and described in the supplementary file in detail. In 
order to ease the comparison between different experiments, the permeability 
coefficient values of the control experiments were set to 100% and the other results 
within the same experiment were normalized to the 100% of the control experiment.  
 
2.3. mRNA analysis 
mRNA analysis is described in the supplementary file in detail. In brief. mRNA of 
cells grown on Transwell inserts was isolated with a Nucleospin-RNAII Kit 
(Macherey Nagel, Düren, Germany) according to the manufacturer’s instructions. 
RNA concentrations were determined by means of a Nanodrop ND 2000 
spectrophotometer (FisherScientific, Schwerte, Germany). 1 µg total RNA per sample 
were reversely transcribed to 20 µl cDNA by means of the high capacity cDNA-kit 
(with random primer and RNAse inhibitor) from Applied Biosystems (Life 
Technologies GmbH, Darmstadt, Germany) according to the manufacturer’s 
instruction. qPCR analysis were performed using either FAM-labelled probes for 
18SrRNA (endogenous control, EUK18SrRNA, 4352930-0810022, Taqman®, 
Applied Biosystems), SP-B (Hs00167036_m1 Taqman®, Applied Biosystems), 
caveolin-1 (Hs00971716_m1; Taqman®, Applied Biosystems) and RAGE 
(Hs00153957_m1, Taqman®, Applied Biosystems) or primers from MWG Eurofins 
(Ebersberg, Germany) for claudin-1, claudin-3, claudin-4, claudin-5, occludin, ZO-1, 
and 18SrRNA. Primer sequences and detailed qPCR conditions are described in the 
supplementary file. qPCR analysis were conducted by means of a 7300 Real-Time 
PCR System (Applied Biosystems). Each sample was analyzed as triplicate. Relative 
Original publication in: Neuhaus et al., Differentiation 84 (2012) 294-304.; 
http://dx.doi.org/10.1016/j.diff.2012.08.006 
 - 9 - 
mRNA abundances to 18S rRNA were calculated by the dCt method using following 
formula: 2(Ct of 18S rRNA-Ct of gene of interest), where Ct is the threshold cycle value. For the 
qualitative proof of the presence of tight junctional proteins cDNA samples were 
amplified with a 2720 Thermal Cycler (Applied Biosystems) and amplification 
products were separated on a 2 % agarose gel in TAE-buffer with a peqGOLD 50 bp 
DNA-ladder (PEQLAB Biotechnologie GmbH, Erlangen, Germany) as marker at 90 
V for half an hour. Bands were then visualised by UV-excited ethidium bromide using 
an ImageMaster VDS (Pharmacia Biotech). 
 
2.4. Western blotting 
Western blotting analysis is described in the supplementary file in detail. In brief, 
H441 cells cultured on 6-well inserts were scraped in RIPA buffer on ice. Sample’s 
protein concentrations were determined by a Pierce BCA assay (FisherScientific). 20 
µg protein per lane for claudin-1,-3,-4 and RAGE, 30 µg protein per lane for claudin-
5, SP-B and caveolin-1 analysis were loaded onto 15% SDS-PAGE gels. After gel 
electrophoresis proteins were immunoblotted onto PVDF membranes by means of a 
semi-dry blotter. Membranes were blocked with 5% milk powder in PBS for 1 hour 
and primary antibodies were applied in 0.5% BSA/PBS solution at 4°C over night. 
Antibodies against claudin-1, claudin-3, claudin-5 (all 1:200), SP-B and caveolin-1 
(1:100) were rabbit polyclonal (519000, 341700, 341600, Zymed®, Life technologies; 
sc-894, sc-13978, Santa Cruz Biotechnology, Heidelberg, Germany), antibodies 
against claudin-4 (1:200, 329400, Zymed®, Life technologies) and β-actin (1:15000, 
A5441, Sigma) were mouse monoclonal and antibody against RAGE (1:100, sc-8230, 
Santa Cruz Biotechnoloy) was goat polyclonal. Membranes were washed with 0.1% 
Tween 20/PBS for three times for 10 minutes and were blocked a further time with 
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5% milk powder/PBS for 25 minutes at RT. Afterwards membranes were incubated 
with secondary HRP-labelled antibodies diluted 1:1000-5000 in 1% BSA/PBS at RT 
for 1 hour and was then washed for three times with 0.1% Tween 20/PBS. To 
visualize the bands western blots were incubated with ECL-solutions for 2 minutes 
and were developed using a FluorChem FC2 Multiimager II (Alpha Innotech). 
Density values of the single tight junction protein bands were calculated with the 
software Alpha View and were related to the appropriate β-actin bands.  
 
2.5. Immunofluorescence microscopy 
Immunofluorescence microscopy was carried out as published recently (Neuhaus et 
al., 2008) and is described in the supplementary file in detail.  
 
2.6. Data analysis 
Data are presented as means±SD. The statistical significance between culture 
conditions was determined by a t-test utilizing SigmaStat3.5 software. In case of test 
failure on normality or equality of variance of the used data set, a Mann-Whitney 
Rank Sum Test was carried out. A probability value less than 0.05 was considered 
statistically significant.  
 
3. Results  
 
3.1. Dexamethasone influences tightness of the barrier in a concentration 
dependent manner  
After five days of culture of H441 cells onto 6-well Transwell inserts, the surface was 
approximately 80% confluent and dexamethasone was added apically in different 
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concentrations. Figure 1A shows the time course of TEER values of H441 cell layers 
treated with dexamethasone. H441 cell layers grown in medium without 
dexamethasone started to form holes on days 8-10 until cells completely detached on 
days 13-15. TEER values were partly still measurable in these time frames, but light 
microscopic control revealed holes and detachment of the cells indicating that 
dexamethasone was necessary to stabilize the confluent layer onto the inserts after 
reaching confluence. Highest TEER values of confluent cell layers were detected on 
days 14-15. Addition of 10 nmol/l dexamethasone increased TEER from 122 ± 33 
Ohm*cm2 to 438 ± 9 Ohm*cm2 on day 15, whereas 100 nmol/l elevated TEER only 
to 322 ± 17 Ohm*cm2 (p<0.05, mean ± SD, n=3). This concentration dependent 
negative tendency was confirmed including data of 30 nmol/l (400 ± 16 Ohm*cm2), 
300 nmol/l (245 ± 13 Ohm*cm2) and 1 µmol/l (207 ± 11 Ohm*cm2) dexamethasone.  
 
3.2. Tight junction proteins claudin-1,-3,-4,-5, occludin and ZO-1 are expressed 
in the alveolar epithelium in vitro model 
In order to investigate the presence of some main tight junctional proteins in our 
model, mRNA analysis of claudin-1, claudin-3, claudin-4, claudin-5, occludin and 
ZO-1 of H441 samples of day 15 treated with 100 nmol/l dexamethasone (apical 
addition) was accomplished. PCR products separated on an agarose gel confirmed the 
presence of all analyzed tight junctional molecules, but the band of claudin-5 was 
very weak indicating low expression (figure 1B). Thus, qPCR with GAPDH as 
endogenous control was carried out in order to rank the abundances of the tight 
junctional proteins which were then related to claudin-1. Claudin-4 was the most 
abundant (7-fold) tight junctional protein, followed by occludin (4-fold), ZO-1 (1.24-
fold), claudin-1 (1-fold) and claudin-3 (0.46-fold). Confirming the agarose gel result 
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claudin-5 exhibited the weakest, but detectable mRNA expression (0.001-fold). In 
order to confirm the presence of tight junction proteins on the protein level, 
immunofluorescence images of H441 cells (day 15) treated with 100 nmol/l 
dexamethasone were generated. As shown in figure 1C, pictures demonstrate the 
presence of claudin-1, claudin-3, claudin-4, claudin-5, occludin and ZO-1 in H441 
cells grown on Transwell inserts for 15 days also on the protein level. In concordance 
with the low mRNA expression of claudin-5, only for claudin-5 it was not able to 
present a continuous tight junction network over the entire H441 cell layer.  
 
3.3. Dexamethasone modulates expression of ATI markers caveolin-1 and RAGE 
as well as of ATII marker SP-B 
One major aim was to generate a model consisting of cells expressing ATI as well as 
ATII markers in order to mimic both types of alveolar epithelial cells in one model. 
Therefore, the expression of mRNA for the ATI markers, caveolin-1 and RAGE, as 
well as the ATII marker, SP-B, was examined in the presence and absence of 
dexamethasone by qPCR. For this, H441 cells were grown on Transwell inserts as 
before for the TEER-experiments and were lysed for mRNA analysis on days 7 and 
15. ATI markers caveolin-1 and RAGE were regulated in a similar manner. As shown 
in figure 2A, mRNA expression of caveolin-1 as well as RAGE did not change 
significantly on day 7 after apical addition of 10 or 100 nmol/l dexamethasone on day 
5, but was significantly decreased to 0.37-fold (caveolin-1, 10 nmol/l dexamethasone, 
p<0.05) or to 0.64-fold (RAGE, 10 nmol/l dexamethasone, p<0.05) on day 15 in 
comparison to the non-treated control of day 7. Interestingly, the treatment of H441 
cells with 100 nmol/l dexamethasone revealed a statistically significant increase of 
caveolin-1 (p<0.05) and RAGE (p<0.05) mRNA expression compared to the 10 
Original publication in: Neuhaus et al., Differentiation 84 (2012) 294-304.; 
http://dx.doi.org/10.1016/j.diff.2012.08.006 
 - 13 - 
nmol/l dexamethasone treated cells on day 15. Untreated H441 samples of day 15 
were not obtainable since the cells started to detach at days 8-10 as mentioned above. 
In case of cell type 2 marker SP-B, dexamethasone induced SP-B expression very 
significantly in a concentration dependent manner. For example, 10 nmol/l 
dexamethasone increased SP-B expression on day 7 7.9-fold (p<0.05). which was 
further increased by 100 nmol/l to 107.8-fold (p<0.05). On day 15 SP-B mRNA 
expression of dexamethasone treated samples was still higher than on day 7 without 
dexamethasone, but decreased in comparison to day 7 dexamethasone treated 
samples. In detail, H441-cells treated with 10 nmol/l dexamethasone revealed a 2.3-
fold SP-B expression and 100 nmol/l dexamethasone application still increased SP-B 
expression 16-fold in comparison to the 7 days old untreated cell samples (p<0.05). In 
order to confirm the presence of type 1 and type 2 cell markers caveolin-1, RAGE and 
SP-B on the protein level immunofluorescence images of H441 cells (day 15) treated 
with 100 nmol/l dexamethasone were generated. As shown in figure 2B, pictures 
demonstrate the presence of caveolin-1, RAGE and SP-B in H441 cells grown on 
Transwell inserts for 15 days also on the protein level. Caveolin-1 was found at the 
cell boarders, whereas RAGE and SP-B were recognizable in the cytosol.  
 
3.4. Soluble factors derived from lung endothelial cells enhance, but from brain 
endothelial cells decrease the tightness of the alveolar epithelial barrier  
In order to study the effects of soluble factors derived from the lung endothelial cell 
line HPMEC-ST1.6R, H441 cells were seeded on the apical side of the Transwell 
inserts. In the apical compartment H441 cells were fed with H441 growth medium as 
before, whereas different growth media were added in the basolateral side during the 
entire cultivation. The effects of ST1-medium, conditioned ST1-medium, D3-medium 
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and conditioned D3-medium were studied in comparison to the original H441 
medium. Conditioned ST1-medium was obtained from lung endothelial cell line 
HPMEC-ST1.6R, conditioned D3-medium from human brain microvascular cell line 
hCMEM/D3, whereas ST1 and D3-medium represent the fresh, unconsumed growth 
media. It was decided to add 100 nmol/l dexamethasone to the apical side beginning 
on day 5 in order to obtain cell layers with a distinct barrier (ATI cell feature), but 
also a maximum of SP-B expression (ATII cell feature). Highest tightness of H441 
cell layers was achieved after 15 days of culture (figure 1A), thus data comparison 
focused on this time point.  
Figure 3 depicts the influence of the different growth media on TEER and 
permeability of the paracellular marker fluorescein across H441 cell layers. In 
comparison to the standard H441 medium (set to 100%), basolateral addition of 
conditioned ST1 medium increased TEER of H441 cell layers significantly to 127.1 ± 
6.4 % (p<0.05). In contrast to ST1 media, basolaterally added conditioned D3 
medium derived from the human blood-brain barrier cell line hCMEC/D3 decreased 
TEER to 44.1 ± 9.7 %, which was significantly different from both H441 and fresh 
D3 medium (both p<0.01).  
In order to support TEER data, additional permeability experiments with the 
paracellular marker fluorescein were carried out. Calculated permeability coefficients 
were between 0.22-3.35 µm/min. To facilitate data comparability, permeability 
coefficients obtained across cell layers grown in H441 medium in both compartments 
were set to 100 % and the others were related to them. Basolaterally added ST1 
medium decreased fluorescein permeability to 85.3 ± 4.7 %, which was further 
decreased by conditioned ST1 medium to 61.1 ± 1.5 %. These differences were 
statistically significant (ST1 vs. H441: p<0.05, ST1 cond. vs. H441: p<0.01, ST1 vs. 
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ST1 cond.: p<0.01) and confirmed TEER data that soluble factors secreted from lung 
endothelial cells maintain or even enhance the barrier in our alveolar epithelium in 
vitro model. In concordance to the TEER data, application of conditioned D3 medium 
increased the permeability of fluorescein to 279.2 ± 4.6 % in comparison to 
basolateral H441 medium. Basolateral fresh D3 medium did not change the 
permeability of fluorescein significantly.  
 
3.5. Alterations of the expression patterns of claudins accord with tightness 
changes of the alveolar barrier  
In order to investigate the functional changes of the tightness on the molecular level 
the expression of claudin-1, -3, -4 and -5 were analyzed. The changes of mRNA 
expression of claudin-1 and -3 matched well to the observed TEER values (Figure 4). 
mRNA expression of claudin-4 was interestingly increased by both conditioned media 
(ST-1 cond.: 1.28 ± 0.19 –fold; D3 cond.: 1.48 ± 0.11-fold) and were statistically 
significant in comparison to their corresponding fresh media. In the case of claudin-5 
no significant changes were detected. 
In order to confirm mRNA data and to include possible non-genomic effects on the 
tight junction molecules, the expression of the proteins was also analyzed by western 
blotting. The influence of growth media on the protein expression of claudin-1 and 
claudin-3 was similar to the effects onto the mRNA expression as well as on TEER. 
However, only the differences of samples treated with conditioned D3-medium 
(claudin-1: 46.7 ± 0.05 %; claudin-3: 68.9 ± 0.06 %) exhibited a statistically 
significant reduction in comparison to the fresh D3 medium (claudin-1: 91.1 ± 0.08 
%; claudin-3: 144 ± 29.9 %) as well as to the H441-medium (p<0.05, mean ± SD, 
n=3). In the case of claudin-4 no significant difference was detected on the protein 
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level. In contrast to mRNA data of claudin-5, analysis of protein amounts of claudin-5 
revealed significant differences. ST1 medium increased claudin-5 expression to 192.1 
± 69.1 % (p<0.05, mean ± SD, n=3), which was further elevated to 225.6 % by 
conditioned ST1 medium, whereas conditioned medium of brain endothelial cells (D3 
cond.) decreased claudin-5 expression to 48.8 ± 15.7 % (p<0.05, mean ± SD, n=3)  
 
3.6. Soluble factors of lung and brain endothelial cells modulate the expression of 
ATI markers caveolin-1 and RAGE as well as of ATII marker SP-B  
In order to assess whether the changes of the H441 barrier by soluble factors of lung 
and brain endothelial cells correlated with alterations of ATI and ATII markers, 
mRNA and protein expressions of caveolin-1, RAGE and SP-B were analyzed. On the 
mRNA level caveolin-1 was significantly upregulated 2.28-fold (p<0.05) by 
conditioned D3-medium, which was concordant with a 2.75-fold increase of the 
protein expression (not significant). In contrast to caveolin-1, mRNA of the second 
ATI marker RAGE was significantly downregulated by the conditioned ST1 medium 
(0.49-fold, p<0.05) as well as by the conditioned D3 medium (0.67-fold, p<0.05). 
This was also confirmed by the according western blot data (ST1 cond.: 0.78-fold, 
n.s.; D3 cond.: 0.82-fold, p<0.05). Similar to caveolin-1, ATII marker SP-B was 
significantly upregulated 2.51-fold by conditioned D3 medium on the mRNA level, 
which was consistent with the 2.51 fold increase of SP-B protein expression. In 
summary, the two ATI markers caveolin-1 and RAGE were differentially regulated by 
soluble factors of lung or brain endothelial cells. Furthermore, no direct correlation 
between the expression of ATI marker expression and barrier functionality was found.  
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4. Discussion  
 
The alveolar epithelial barrier function is involved in different pulmonary physiology 
processes, such as fluid homeostasis, defence mechanisms and gas exchange. Also in 
pulmonary disease the alveolar epithelial barrier has been shown to play a central role 
(Godfrey, 1997; Matthay, 1994). Clinical studies have highlighted the importance of 
this intact barrier function to clinical outcomes (Maniatis et al., 2008; Ware and 
Matthay, 2000, 2001). Since the microenvironment (neighbouring cells, basal matrix) 
of biological barriers in mammalian organisms can regulate the barrier’s functionality 
in a significant manner, we aimed at investigating the influence of the lung 
endothelium on the alveolar epithelium in an in vitro model.  
Up to now, only few in vitro models based on stable cell lines of the alveolar 
epithelium are established, which consist of cells expressing either type I or type II 
markers and form a tight barrier (Hermanns et al., 2004, 2009, 2010). Currently, only 
two promising cell lines are available to model the alveolar epithelium, namely A549 
and NCI H441. Several reports showed that cell line A549 is useful as a type II cell 
model. However, attempts to transdifferentiate them into type I cells and build up a 
sufficient barrier have failed until now (Hermanns et al., 2004). In case of H441 cells, 
recent publications showed that treatment of H441 cells with dexamethasone leads to 
the upregulation of the type-2 marker, SP-B, to dome formation, to a tight barrier and 
an increase of the expression of tight junctional molecule claudin-4 (Hermanns et al., 
2004; Ladenburger et al., 2010; Shlyonsky et al., 2005). Consequently, we decided to 
establish an alveolar cell culture model based on human cell line H441 and to use this 
model to study the influence of soluble factors derived from lung as well as from 
brain endothelial cells.  
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First, in order to validate this cell culture model the influence of dexamethasone on 
the barrier (TEER) and on the expression of caveolin-1, RAGE (type-1 markers) and 
SP-B (type-2 marker) was investigated. It was known from other studies with primary 
alveolar type II cells as well as cell lines that addition of dexamethasone or 
hydrocortisone was necessary to form a barrier (Daugherty et al., 2004; Hermanns et 
al., 2004; Hermanns et al., 2009; Steimer et al., 2007). To our best knowledge, we are 
the first to present data showing that the tightness of the H441 barrier is dependent on 
the dexamethasone concentration. This seems to be important considering the fact that 
reseachers applied dexamethasone in a rather wide concentration range (50 nmol/l – 1 
µmol/l) for their H441 studies (Hermanns et al., 2010; Shlyonsky et al., 2005). One 
major aim of the establishment of the H441-model was to generate tight cell layers 
which at the same time possess type I and type II markers. Previous studies showed 
that H441 layers treated with dexamethasone were able to exhibit several properties of 
the alveolar epithelium such as apical villi, laminar as well as multivesicular bodies, 
type-2 marker TTF-1 as well as epithelial marker E-cadherin (Hermanns et al., 2004, 
2010). Thus, we have decided to concentrate on the analysis of the markers caveolin-
1, RAGE and SP-B in order to present relevant, but also novel data of H441 cells 
concerning the presence of both cell types within the H441 Transwell model. 
Ladenburger et al. (2010) showed recently that dexamethasone was able to increase 
SP-B in H441 cells significantly. This was concordant with our results where 
dexamethasone increased SP-B in a concentration dependent manner, whereas 
caveolin-1 and RAGE expression was not altered compared to the untreated samples 
on day 7. Interestingly, immunofluoresence microscopy of double-stainings against 
caveolin-1 and SP-B showed cells expressing caveolin-1 but not SP-B at the same 
time confirming the presence of two differentially differentiated cell types in the 
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H441-layers representing type 1 and type 2 cells (see supplementary file, figure 2). So 
we were able to show that the established H441 model consists of cells expressing 
both type 1 (caveolin-1, RAGE) and type 2 (SP-B) markers on the mRNA as well as 
on the protein level and that the marker expression can be regulated by 
dexamethasone.  
With regard to the tightness of the established H441-Transwell model, TEER values 
indicated that the chosen culture conditions resulted in a distinct barrier which is 
associated on the molecular level with the presence of tight junctional proteins. For 
the alveolar epithelium the presence of claudin-1,-3,-4,-5,-7 and 18 were reported 
(Daugherty et al., 2004; Kaarteenaho et al., 2010; Koval et al., 2010; Wang et al., 
2003). Claudins are important for a stable barrier of the alveolar epithelium in health 
as well as in disease (Capaldo and Nusrat, 2009; Coyne et al., 2002; Crosby and 
Waters, 2010; Daugherty et al., 2004; Godfrey et al., 1993; Lecuona et al., 1999; 
Soini, 2011; Wray et al., 2009). We have analyzed the presence of ZO-1, occludin, 
claudin-1,-3,-4 and -5 on the mRNA as well as on the protein level in our established 
H441-model. In case of ZO-1 and occludin, their presence was already shown for 
H441 layers (Hermanns et al., 2004, 2010; Shlyonsky et al., 2005), whereas the 
analysis of claudin expression was carried out for the first time. In comparison to 
claudin-1,-3 and -4, the expression of claudin-5 was very weak in our model. Claudin-
1 is relative specific for type I cells (Daugherty et al., 2004), whereas claudin-3 and 
claudin-4 were found mainly in type II pneumocytes (Kaarteenaho-Wiik and Soini, 
2009). In human lung development claudin-5 was only weakly expressed in the lung 
epithelium during the pseudoglandular and the canalicular phase observed by 
immunofluorescence microscopy. In the later phases (saccular and alveolar) claudin-5 
was not longer detected and only found in the surrounding lung microvasculature 
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(Kaarteenaho et al., 2010), whereas claudin-3 and claudin-4 were found in the alveoli 
during all developmental stages. These facts supported our data and demonstrate that 
our model mimics several properties of the alveolar epithelium including both type I 
and type II cells of the alveolar epithelium.  
After establishment and characterisation of our H441-model the influence of 
conditioned endothelial growth media on its barrier properties was investigated. 
Recently, it was shown that co-cultures of primary type II cells as well as of H441- 
layers with either primary lung endothelial cells or the endothelial cell line ISO-HAS-
I resulted in significantly increased tightness indicated by an increase of TEER and 
ZO-1 localisation (Hermanns et al., 2009, 2010). In our case, application of 
conditioned medium of HPMEC-ST1.6R cells to the basolateral compartment 
increased the tightness of the H441-layers shown by TEER values and fluorescein 
permeability. On the contrary, conditioned medium of human brain endothelial cells 
hCMEC/D3 decreased the tightness of H441-layers significantly confirming tissue-
specific effects. To link these observations on the functional level to the molecular 
level mRNA as well as protein expression of claudin-1,-3,-4 and -5 and the alveolar 
cell type markers (caveolin-1, RAGE, SP-B) were quantified by qPCR and western 
blotting. Interestingly, almost the same results to ours were found by Fernandez et al. 
(2007), who analyzed the claudin expression patterns of rat lungs after chronic 
alcohol ingestion. Claudin-1 and -3 were reduced in lung tissue, whereas claudin-4 
was unchanged. Also concordant to our results, they found no changes of claudin-5 
mRNA, but reported changes of claudin-5 on the protein level. This confirmed our 
assumption that claudin-5 is regulated on the posttranscriptional level. Up-regulation 
of claudin-5 was reported in alveolar epithelial cell layers with increased tightness 
(Wang et al., 2003). Since the basal expression of claudin-5 in our H441-cells is quite 
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low in comparison to claudin-1,-3 and -4, a significant regulation of claudin-5 is 
maybe connected with a significant change in barrier functionality. In this context, we 
were able to observe a distinct up-regulation of the claudin-5 network of H441-layers 
fed basolaterally with fresh ST1-medium by immunofluorescence microscopy (see 
supplementary file, figure 1). With regard to the ATI and ATII markers, no direct 
correlation was found between changes of the barrier tightness and the expression of 
caveolin-1, RAGE or SP-B. Notably, caveolin-1 and SP-B were regulated in a similar 
manner, whereas RAGE expression decreased due to addition of conditioned 
endothelial medium independent from the tissue origin. These data showed that the 
two ATI markers caveolin-1 and RAGE reacted differently on the endothelial factors 
in our model suggesting differences in their usability as ATI markers. This was 
concordant to the classification of ATI markers by McElroy and Kaspar (2004). They 
added caveolin-1 to the group of ATI selective proteins, but RAGE only to the ATI 
selective/associated markers, since mRNA of RAGE was also detected in ATII cells 
(McElroy and Kaspar, 2004).  
In summary, after validation of the H441-cell culture as an alveolar epithelium model 
consisting of cells expressing either ATI or ATII markers, it was shown for the first 
time that soluble factors of lung endothelial cells (HPMEC-ST1.6R) enhance the 
barrier of the alveolar epithelium. Furthermore, this functional improvement of the 
barrier was linked with the quantitative expression of claudins on the mRNA as well 
as on the protein level. Moreover, soluble factors of brain endothelial cells 
(hCMEC/D3) disrupted the barrier’s integrity proving tissue-specific effects of 
endothelial cells. With regard to the clinical context, influencing the alveolar 
permeability by manipulation of the claudin expression may be a future target in the 
treatment of different lung diseases (Soini, 2011). 
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Figure Captions 
 
Fig. 1. Concentration dependent influence of dexamethasone on the time courses of 
TEER development of H441-cell layers (A). Presence of tight junction molecules 
claudin-1 (233 bp), claudin-3 (247 bp), claudin-4 (187 bp), claudin-5 (239 bp), 
occludin (170 bp) and ZO-1 (224 bp) is proven on mRNA level of H441-layers 
treated with 100 nmol/l dexamethasone (apical) and lysed on day 15, relative 
abundances were determined by qPCR presented in the table below the agarose gel 
image (B). Immunofluorescence microscopic images of H441-layers (day 15) treated 
with 100 nmol/l dexamethason (apical) prove the presence on the protein level and 
localisation at the plasma membrane of claudin-1, -3,-4 and -5, occludin and ZO-1 
(green=tight junction protein, red=propidium iodide stained nuclei) (C). In the case of 
claudin-5, low predicted abundance by mRNA analysis was confirmed and visualized 
by immunofluorescence microscopy. 
Fig. 2. Concentration dependent influence of dexamethasone on the mRNA 
expression of cell type-I markers caveolin-1 and RAGE and cell type-II marker SP-B 
in H441-cell layers on day 7 and day 15 determined by qPCR (A). 
Immunofluorescence microscopic images of H441-layers (day 15) treated with 100 
nmol/l dexamethason (apical) prove the presence on the protein level and the expected 
localisation of caveolin-1, RAGE and SP-B. (green=marker protein, red=propidium 
iodide stained nuclei) (B). Data are presented as means ± SD (n=3). Statistically 
significant differences are marked by * (p<0.05, t-test) in comparison to the samples 
of non-treated cells and by # (p<0.05, t-test) in comparison to 10 nmol/l 
dexamthasone treated cells on day 15. 
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Fig. 3. Influence of soluble factors from lung and brain endothelial cells on the barrier 
of the H441 model. H441 cells were fed basolaterally with fresh or conditioned 
growth media from human lung endothelial cell line HPMEC-ST1.6R (ST1) or from 
human brain endothelial cell line hCMEC/D3 (D3) for 15 days, 100 nmol/l 
dexamethasone was added in the apical side with every medium exchange from day 5 
on. Changes of the barrier functionality of H441 layers were measured by TEER (A) 
and by the permeability of paracellular marker fluorescein (B). H441 means 
conventional H441 growth medium, ST1 and D3 are the fresh growth media for 
HPMEC-ST1.6R and hCMEC/D3 cells, whereas ST1-cond. and D3-cond. means the 
conditioned growth media obtained from HPMEC-ST1.6R and hCMEC/D3 cells. 
Data are normalized to data obtained from H441 cell layers grown in H441-medium 
which were set to 100% and are presented as means ± SD (n=3). Statistically 
significant differences are marked by # (p<0.05, t-test) in comparison to H441-growth 
medium and by * (p<0.05, t-test) in comparison to the according fresh medium ST1 
or D3. 
Fig. 4. Influence of soluble factors from lung and brain endothelial cells on the 
mRNA expression of claudins of H441 layers. H441 cells were fed basolaterally with 
fresh or conditioned growth media from human lung endothelial cell line HPMEC-
ST1.6R (ST1) or from human brain endothelial cell line hCMEC/D3 (D3) for 15 days, 
100 nmol/l dexamethasone was added in the apical side with every medium exchange 
from day 5 on. Changes of the mRNA expression of claudin-1, claudin-3, claudin-4 
and claudin-5 of H441 cell layers were measured by qPCR. H441 means conventional 
H441 growth medium, ST1 and D3 are the fresh growth media for HPMEC-ST1.6R 
and hCMEC/D3 cells, whereas ST1-cond. and D3-cond. means the conditioned 
growth media obtained from HPMEC-ST1.6R and hCMEC/D3 cells. Data are 
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normalized to data obtained from H441 cell layers grown in H441-medium which 
were set to 1 and are presented as means ± SD (n=3). Statistically significant 
differences are marked by * (p<0.05, t-test) in comparison to the according fresh 
medium ST1 or D3. 
Fig. 5. Influence of soluble factors from lung and brain endothelial cells on the 
protein expression of claudins of H441 layers. H441 cells were fed basolaterally with 
fresh or conditioned growth media from human lung endothelial cell line HPMEC-
ST1.6R (ST1) or from human brain endothelial cell line hCMEC/D3 (D3) for 15 days, 
100 nmol/l dexamethasone was added in the apical side with every medium exchange 
from day 5 on. Changes of the protein expression of claudin-1, claudin-3, claudin-4 
and claudin-5 of H441 cell layers were measured by western blotting normalized to β-
actin. H441 means conventional H441 growth medium, ST1 and D3 are the fresh 
growth media for HPMEC-ST1.6R and hCMEC/D3 cells, whereas ST1-cond. and 
D3-cond. means the conditioned growth media obtained from HPMEC-ST1.6R and 
hCMEC/D3 cells. One representative western blot out of three with similar results is 
shown. Data are normalized to data obtained from H441 cell layers grown in H441-
medium which were set to 1 and are presented as means ± SD (n=3 per condition). 
Statistically significant differences are marked by # (p<0.05, t-test) in comparison to 
H441-growth medium and by * (p<0.05, t-test) in comparison to the according fresh 
medium ST1 or D3. 
 
Fig. 6. Influence of soluble factors from lung and brain endothelial cells on the 
mRNA as well as protein expression of cell type-I markers caveolin-1 and RAGE and 
cell type-II marker SP-B of H441 layers. H441 cells were fed basolaterally with fresh 
or conditioned growth media from human lung endothelial cell line HPMEC-ST1.6R 
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(ST1) or from human brain endothelial cell line hCMEC/D3 (D3) for 15 days, 100 
nmol/l dexamethasone was added in the apical side with every medium exchange 
from day 5 on. Changes of the expression of caveolin-1, RAGE and SP-B of H441 
cell layers were measured by qPCR (mRNA) or western blotting normalized to β-
actin (protein). H441 means conventional H441 growth medium, ST1 and D3 are the 
fresh growth media for HPMEC-ST1.6R and hCMEC/D3 cells, whereas ST1-cond. 
and D3-cond. means the conditioned growth media obtained from HPMEC-ST1.6R 
and hCMEC/D3 cells. One representative western blot out of three with similar results 
is shown. Data are normalized to data obtained from H441 cell layers grown in H441-
medium which were set to 1 and are presented as means ± SD (n=3 per condition). 
Statistically significant differences are marked by # (p<0.05, t-test) in comparison to 
H441-growth medium and by * (p<0.05, t-test) in comparison to the according fresh 
medium ST1 or D3. 
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Figure 1 
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Figure 2 
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Figure 3 
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Figure 4 
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Figure 5 
 
 
 
Original publication in: Neuhaus et al., Differentiation 84 (2012) 294-304.; 
http://dx.doi.org/10.1016/j.diff.2012.08.006 
 - 38 - 
Figure 6 
 
 
